Intriguingly, Yu et al. demonstrated that LIFR-deficient pancreatic cancer cells are more sensitive to GEM and that the intrinsic GEM resistance of tumor-initiating cells relies on LIFR signaling [39]. The gene discussed is LIFR; the disease is pancreatic neoplasm.